Personal information

No personal information available

Activities

Employment (3)

Aspen Neuroscience: Winchester, MA, US

2022-10-31 to present | Vice President (Bioinformatics)
Employment
Source: Self-asserted source
Ethan Xu

Excision BioTherapeutics: Cambridge, MA, US

2021-05-03 to 2022-10-21 | Vice President (Bioinformatics)
Employment
Source: Self-asserted source
Ethan Xu

Sanofi Genzyme: Framingham, MA, US

2016-06-27 to 2021-04-30 | Director (Translational Sciences)
Employment
Source: Self-asserted source
Ethan Xu

Education and qualifications (1)

Johns Hopkins Medicine: Baltimore, MD, US

1995-09-01 to 2001-05-24 | Ph.D. (Biochemistry, Cellular and Molecular Biology)
Education
Source: Self-asserted source
Ethan Xu

Professional activities (2)

American Society of Gene & Cell Therapy: Waukesha, WI, US

2021-05-05 to present
Membership
Source: Self-asserted source
Ethan Xu

American Association for Cancer Research: Philadelphia, PA, US

2016-04-01 to 2022-03-31 | Active Member
Membership
Source: Self-asserted source
Ethan Xu

Works (15)

Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates.

Gene therapy
2023-08-17 | Journal article
Contributors: Burdo TH; Chen C; Rafal Kaminski; Sariyer IK; Pietro Mancuso; Donadoni M; Smith MD; Sariyer R; Caocci M; Liao S et al.
Source: Self-asserted source
Ethan Xu

Molecular Features and Stages of Pulmonary Fibrosis Driven by Type 2 Inflammation.

American journal of respiratory cell and molecular biology
2023-06-27 | Journal article
Contributors: Mattoo H; Bangari DS; Cummings S; Humulock Z; Habiel D; Xu EY; Pate N; Resnick R; Savova V; Qian G et al.
Source: Self-asserted source
Ethan Xu

Anti-microRNA-21 Therapy on Top of ACE Inhibition Delays Renal Failure in Alport Syndrome Mouse Models

Cells
2022-02-09 | Journal article
Contributors: Diana Rubel; Joseph Boulanger; Florin Craciun; Ethan Y. Xu; Yanqin Zhang; Lucy Phillips; Michelle Callahan; William Weber; Wenping Song; Nicholas Ngai et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Blood phenylalanine reduction reverses gene expression changes observed in a mouse model of phenylketonuria.

Scientific reports
2021-11-24 | Journal article
Source: Self-asserted source
Ethan Xu

Small RNA sequencing evaluation of renal microRNA biomarkers in dogs with X-linked hereditary nephropathy.

Scientific reports
2021-08-31 | Journal article
Source: Self-asserted source
Ethan Xu

ZIAQ: a quantile regression method for differential expression analysis of single-cell RNA-seq data

Bioinformatics
2020-05-01 | Journal article
Contributors: Wenfei Zhang; Ying Wei; Donghui Zhang; Ethan Y Xu; Lenore Cowen
Source: check_circle
Crossref

Dysregulated Expression of microRNA-21 and Disease-Related Genes in Human Patients and in a Mouse Model of Alport Syndrome

Human Gene Therapy
2019-07 | Journal article
Part of ISSN: 1043-0342
Contributors: Jifan Guo; Wenping Song; Joseph Boulanger; Ethan Y. Xu; Fang Wang; Yanqin Zhang; Qun He; Suxia Wang; Li Yang; Cynthia Pryce et al.
Source: Self-asserted source
Ethan Xu via Crossref Metadata Search

Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199)

Leukemia
2016 | Journal article
Part of ISSN: 0887-6924
Contributors: V M Patel; K Balakrishnan; M Douglas; T Tibbitts; E Y Xu; J L Kutok; M Ayers; A Sarkar; R Guerrieri; W G Wierda et al.
Source: Self-asserted source
Ethan Xu via Crossref Metadata Search

An integrated hierarchical Bayesian approach to normalizing left-censored microRNA microarray data

BMC Genomics
2013 | Journal article
Part of ISSN: 1471-2164
Contributors: Jia Kang; Ethan Xu
Source: Self-asserted source
Ethan Xu via Crossref Metadata Search

Stitching together Multiple Data Dimensions Reveals Interacting Metabolomic and Transcriptomic Networks That Modulate Cell Regulation

PLoS Biology
2012-04-03 | Journal article
Part of ISSN: 1545-7885
Contributors: Jun Zhu; Pavel Sova; Qiuwei Xu; Kenneth M. Dombek; Ethan Y. Xu; Heather Vu; Zhidong Tu; Rachel B. Brem; Roger E. Bumgarner; Eric E. Schadt et al.
Source: Self-asserted source
Ethan Xu via Crossref Metadata Search

Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways.

Current opinion in drug discovery & development
2009-01-01 | Journal article
Source: Self-asserted source
Ethan Xu

Integrated Pathway Analysis of Rat Urine Metabolic Profiles and Kidney Transcriptomic Profiles To Elucidate the Systems Toxicology of Model Nephrotoxicants

Chemical Research in Toxicology
2008-08 | Journal article
Part of ISSN: 0893-228X
Contributors: Ethan Yixun Xu; Ally Perlina; Heather Vu; Sean P. Troth; Richard J. Brennan; Amy G. Aslamkhan; Qiuwei Xu
Source: Self-asserted source
Ethan Xu via Crossref Metadata Search

Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.

Journal of virology
2001-11-01 | Journal article
Source: Self-asserted source
Ethan Xu

Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9.

Journal of virology
2001-04-01 | Journal article
Source: Self-asserted source
Ethan Xu

A YAC-based physical map of the mouse genome.

Nature genetics
1999-08-01 | Journal article
Source: Self-asserted source
Ethan Xu